Progesterone is a steroid hormone that plays a central role in reproduction, pregnancy, brain function, and cardiovascular health. While most people associate it with the menstrual cycle and pregnancy, progesterone acts on nearly every organ system, including in men. Its influence on mood, immune tolerance, and even traumatic brain injury recovery has reshaped how researchers think about this hormone, and the medical distinction between natural progesterone and synthetic substitutes turns out to matter more than was once appreciated.
Where Progesterone Comes From
The body makes progesterone from cholesterol through a two-step conversion. First, an enzyme complex in the mitochondria clips off the side chain of cholesterol to produce a precursor called pregnenolone. Then a second enzyme in the smooth endoplasmic reticulum converts pregnenolone into progesterone.1Reproduction. Molecular control of luteal secretion of progesterone The primary factory for this conversion in women of reproductive age is the corpus luteum, the temporary structure that forms in the ovary after an egg is released. Luteinizing hormone drives the whole process, switching on genes that pull cholesterol from circulating lipoproteins, store it, shuttle it into mitochondria, and run it through those two enzymatic steps.2Academic Press. Molecular Regulation of Progesterone Production in the Corpus Luteum
During pregnancy, the placenta takes over as the main source by around the eighth to tenth week, producing far more progesterone than the corpus luteum ever could. The adrenal glands also make small amounts in both sexes, and the testes produce progesterone in men, where it serves functions that are often overlooked.
The Menstrual Cycle and Preparing for Pregnancy
After ovulation, the surge in progesterone transforms the uterine lining from a thin, proliferating tissue into a thick, spongy layer rich in blood vessels and secretory glands. This transformation is what makes the endometrium receptive to an embryo. Without adequate progesterone, a fertilized egg cannot successfully implant.3PubMed. Progesterone function in human endometrium: clinical perspectives If pregnancy does not occur, the corpus luteum breaks down, progesterone levels drop sharply, and the uterine lining sheds as a menstrual period.
This rise and fall is why progesterone is sometimes called the “pregnancy hormone,” though the label sells it short. Even before implantation, progesterone thickens cervical mucus, making it harder for sperm and pathogens to pass through the cervical canal. That same mucus-thickening effect is one of the key mechanisms behind progestin-only contraceptives, which work partly by keeping the cervical mucus in a state that restricts sperm access to the egg.4PubMed. Mechanisms that explain the contraceptive action of progestin implants for women
Keeping the Uterus Quiet During Pregnancy
Once pregnancy is established, one of progesterone’s most critical jobs is preventing the uterus from contracting prematurely. It achieves this through several overlapping mechanisms: it increases the activity of potassium channels in the muscle cells of the uterine wall, which dampens their electrical excitability; it dials down receptors and signaling molecules that would otherwise trigger contractions; and it reduces the cross-linking of the muscle filaments that generate contractile force.5PubMed Central. Effects of progesterone treatment on expression of genes involved in uterine quiescence Placental progesterone also blocks inflammatory pathways that would otherwise activate “contractile” genes in the uterine muscle.6PubMed Central. Molecular Regulation of Parturition: A Myometrial Perspective
This is why researchers have long hoped that supplemental progesterone might help prevent preterm birth, and the clinical story there is more complicated than early headlines suggested.
Immune Tolerance and the Fetus
A fetus is genetically half-foreign to the mother’s immune system. Progesterone helps prevent rejection by shifting the immune response in a specific direction. When progesterone binds to receptors on certain immune cells, those cells produce a protein called progesterone-induced blocking factor, or PIBF. This protein steers the immune system toward a less aggressive profile and tamps down the killing activity of natural killer cells.7PubMed. Progestogens and immunology The result is an immune environment that tolerates the developing embryo while still maintaining enough function to fight infections.8PubMed Central. The Role of Extracellular Vesicles and PIBF in Embryo-Maternal Immune-Interactions
Women with recurrent miscarriages sometimes show lower levels of PIBF, which has fueled interest in progesterone supplementation during early pregnancy. The immune angle also helps explain why some autoimmune conditions temporarily improve during pregnancy, when progesterone levels are high, and flare afterward.
Progesterone in the Brain
The brain is not just a passive bystander to progesterone’s reproductive role. The hormone crosses the blood-brain barrier and is converted into a metabolite called allopregnanolone, which acts as a powerful calming agent on the brain’s main inhibitory signaling system. Allopregnanolone enhances the activity of GABA-A receptors, the same receptors targeted by benzodiazepines and alcohol.9PubMed Central. Tolerance to allopregnanolone with focus on the GABA-A receptor At sufficient concentrations, this produces anxiety-reducing and sedative effects.
The relationship between allopregnanolone and mood is not always straightforward. At low concentrations, these GABA-active steroids can paradoxically increase anxiety, while at higher concentrations they have calming properties. This dose-dependent flip is thought to underlie the mood symptoms of premenstrual dysphoric disorder (PMDD), where the normal fluctuations in allopregnanolone levels during the menstrual cycle trigger negative mood symptoms in susceptible women.10PubMed. Allopregnanolone and mood disorders
The most dramatic clinical application of this brain chemistry is brexanolone, an intravenous form of allopregnanolone approved for postpartum depression. After delivery, progesterone and its metabolites plummet. In women vulnerable to this withdrawal, the sudden loss of GABA-enhancing neurosteroids contributes to severe depression and anxiety. Brexanolone essentially replaces the missing allopregnanolone, rapidly relieving mood deficits by restoring GABA-A receptor activation.11PubMed Central. Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy It represented a conceptual breakthrough in psychiatry: rather than treating depression with a traditional antidepressant, the treatment directly addresses the neurosteroid deficit that causes the condition.
Traumatic Brain Injury and Neuroprotection
Progesterone’s brain effects extend beyond mood. Animal research and early clinical trials explored whether the hormone could protect the brain after traumatic injury. Two independent early-phase clinical trials in patients with moderate to severe traumatic brain injury showed promising results. In one, patients who received progesterone within hours of injury had about half the 30-day mortality rate compared to controls, with no serious side effects attributed to the hormone. A second trial in severely injured patients found that mortality at six months was roughly 18% in the progesterone group versus 32% in controls, with better functional outcomes at both three and six months.12PubMed Central. The Role of Progesterone in Traumatic Brain Injury A separate open-label trial also reported improved neurological outcomes at three months in severe TBI patients given intramuscular progesterone.13Acta Pharmacologica Sinica. The neuroprotective effects of progesterone on traumatic brain injury: current status and future prospects
These results generated real excitement, but subsequent larger trials failed to confirm the benefit. The story illustrates a common pattern in neurology: early small trials produce striking results that do not hold up when tested in bigger, more rigorous settings. The neuroprotective mechanisms appear real in animal models, and the hormone clearly reduces brain swelling and inflammation in laboratory settings, but translating that to human treatment has proven elusive so far.
Progesterone in Men
Progesterone is often discussed as though it belongs exclusively to female physiology, but men produce it in the adrenal glands and testes, and it is not merely a leftover of the biosynthetic pathway to testosterone. In men, progesterone influences sperm maturation, the acrosome reaction that allows sperm to penetrate an egg, and testosterone production in the Leydig cells of the testes.14PubMed. Progesterone: the forgotten hormone in men? The brain effects of allopregnanolone described above also apply to men, and some researchers have suggested that declining progesterone levels with age may contribute to sleep disturbances and mood changes in older men, though this area remains underexplored.
The Breast and Mammary Gland Development
Estrogen drives the growth of breast ducts during puberty, but progesterone is responsible for the next stage of development. During pregnancy, progesterone and prolactin together drive the formation of the milk-producing structures called lobuloalveoli.15PubMed Central. The alveolar switch: coordinating the proliferative cues and cell fate decisions that drive the formation of lobuloalveoli from ductal epithelium When the progesterone receptor is absent in mammary tissue, this alveolar development completely fails, even though ductal growth during puberty proceeds normally.16PubMed. Impact of progesterone receptor on cell-fate decisions during mammary gland development This means progesterone signaling specifically controls the tissue remodeling that prepares the breast for lactation, and the receptor triggers a cascade of local growth factor signals that direct nearby cells to proliferate and differentiate.17PubMed. Progesterone signaling in mammary gland development
The same growth-promoting signals that prepare the breast for milk production also raise questions about breast cancer risk with long-term hormone exposure, a topic where the distinction between natural progesterone and synthetic progestins matters considerably.
Natural Progesterone Versus Synthetic Progestins
One of the most clinically relevant distinctions in progesterone science is the difference between the body’s own hormone and the synthetic compounds designed to mimic it. Synthetic progestins, such as medroxyprogesterone acetate (MPA) and norethisterone, were developed to be orally active and have long been used in hormone therapy and contraception. But their chemical structures differ enough from natural progesterone that their effects on metabolism, blood vessels, and breast tissue diverge in important ways.
In the cardiovascular system, natural progesterone does not reverse the beneficial effects of estrogen on blood vessel dilation or lipid profiles. Some synthetic progestins, particularly those derived from testosterone, carry partial androgenic activity that can worsen cholesterol markers and inhibit estrogen’s protective effects on blood vessels. In animal models, adding MPA to estrogen inhibited vasodilation by about half, while natural progesterone and certain non-androgenic derivatives did not diminish estrogen’s vascular benefits.18PubMed. Progestins and cardiovascular risk markers Progesterone itself promotes vasodilation, improves endothelial function, and reduces oxidative stress through both direct and receptor-mediated effects on blood vessel cells.19Steroids. Progesterone and vascular function: mechanisms and therapeutic implications in cardiovascular disease
The breast cancer picture follows a similar pattern. A meta-analysis of cohort studies found that women using estrogen combined with natural progesterone had about a third lower breast cancer risk compared to those using estrogen combined with synthetic progestins.20PubMed Central. Progesterone vs synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis Multiple non-randomized studies have supported the finding that natural progesterone and retroprogesterone carry lower breast risk than synthetic alternatives.21PubMed. Progesterone, progestins and the breast in menopause treatment This matters enormously for women making decisions about menopausal hormone therapy. Micronized progesterone, the pharmaceutical form that is chemically identical to what the body makes, allows for more physiological effects compared to synthetic progestins, whose impacts on metabolic, cardiovascular, and cognitive systems are uneven and not always beneficial.22PubMed Central. Estradiol and Micronized Progesterone: A Narrative Review About Their Use as Hormone Replacement Therapy
Progesterone in Fertility Treatment and Preterm Birth Prevention
After IVF and embryo transfer, the normal corpus luteum is often disrupted, so supplemental progesterone is standard to support the uterine lining during the early weeks of pregnancy. The two main delivery routes are intramuscular injection and vaginal preparations. A matched comparison of the two found no meaningful difference: pregnancy rates were about 50% with both vaginal and intramuscular progesterone, and live birth rates were essentially identical at roughly 47%.23PubMed. Matched-samples comparison of intramuscular versus vaginal progesterone for luteal phase support after in vitro fertilization and embryo transfer
Interestingly, vaginal progesterone produces lower blood levels of the hormone than intramuscular injection, yet it transforms the endometrium just as effectively. This is because of a “first uterine pass effect”: progesterone absorbed through the vaginal walls reaches the uterus at high local concentrations before it gets diluted into the general circulation, which also means fewer systemic side effects like drowsiness.24Human Reproduction Update. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments Oral progesterone, by contrast, is rapidly broken down in the gut and liver and has generally proven inferior for luteal support.
The preterm birth story is more contentious. Vaginal progesterone has been shown to reduce preterm delivery by about 45% and to lower rates of neonatal intensive care admissions and respiratory distress in women who have a short cervix in mid-pregnancy, regardless of whether they have had a prior preterm birth. About 11 women with a short cervix need to be treated to prevent one case of very early preterm birth.25PubMed Central. Progesterone to prevent spontaneous preterm birth But the evidence is weaker for women whose main risk factor is a prior preterm birth rather than a short cervix. The FDA revoked approval of 17-alpha hydroxyprogesterone caproate (a synthetic injectable form) after larger trials found limited benefit, and recent meta-analyses of well-designed trials have found that vaginal progesterone does not significantly reduce recurrent preterm birth in women selected based on history alone.26PubMed. Vaginal progesterone for prevention of preterm birth in women with a history of preterm birth regardless of cervical length: an argument against use The upshot: progesterone appears to work best when the target is women with a measurably short cervix, rather than as a blanket treatment for everyone with a history of preterm delivery.
Menopausal Hormone Therapy and Endometrial Protection
Women who take estrogen for menopausal symptoms and still have a uterus need a progestogen to prevent estrogen from overstimulating the endometrial lining, which can lead to abnormal thickening and raise cancer risk. A systematic review of 84 randomized controlled trials found that most progestogen regimens successfully provided this endometrial protection.27PubMed. Progestogens for endometrial protection in combined menopausal hormone therapy: A systematic review Given the cardiovascular and breast-cancer advantages of natural progesterone over synthetic progestins described above, many clinicians now favor micronized progesterone for this role, though dose and duration still need to be individualized.
Environmental Chemicals That Interfere with Progesterone
Progesterone signaling can be disrupted by environmental chemicals that mimic or block the hormone at its receptor. Computer modeling studies have shown that DEHP, one of the most common phthalate plasticizers, and its breakdown products bind tightly to the progesterone receptor and overlap with the same receptor sites used by actual hormones, raising concerns about interference with normal reproductive function.28PubMed Central. Endocrine disruption: In silico perspectives of interactions of di-(2-ethylhexyl)phthalate and its five major metabolites with progesterone receptor DDT exposure has also been linked to lower progesterone levels during the luteal phase of the menstrual cycle, the window critical for implantation and early pregnancy maintenance.29American Journal of Epidemiology. A Prospective Study of Serum DDT and Progesterone and Estrogen Levels across the Menstrual Cycle in Nulliparous Women of Reproductive Age
Researchers have developed cell-based screening tools to detect progesterone-receptor-interacting chemicals in environmental samples. When one such assay was used to test water from two major rivers in Virginia, low but reproducible progesterone-mimicking activity was detected at about a third of the sites sampled.30Journal of the Endocrine Society. Novel Assay for Detection of Progesterone Receptor-Interacting Endocrine Disruptors These chemicals can act as either agonists or antagonists at the progesterone receptor, meaning they could either over-activate or suppress normal signaling. The consequences for wildlife and human reproductive health are still being mapped, but the concern is real enough to drive ongoing environmental monitoring.
An Ancient Signaling System
Progesterone signaling is not a recent evolutionary invention. The membrane-bound progesterone receptors, the class that sits on cell surfaces rather than inside the nucleus, first appeared in non-bilaterian animals, organisms that predate the evolution of a left-right body plan. The classical nuclear progesterone receptor evolved later, in early vertebrates. The membrane receptor gene family likely expanded through several rounds of gene duplication from a single ancestral sequence.31PubMed Central. Genomic sequence analyses of classical and non-classical lamprey progesterone receptor genes and the inference of homologous gene evolution in metazoans The fact that progesterone receptors were already present in some of the earliest animal lineages suggests the hormone has been influencing cell behavior for hundreds of millions of years, long before anything resembling a uterus or a menstrual cycle existed. Whatever progesterone was originally doing in those ancient organisms, reproduction co-opted an already sophisticated signaling toolkit rather than building one from scratch.
How Progesterone Became a Pharmaceutical
The story of how progesterone went from a biological molecule to a drug people can take is tied to a chemist named Russell Marker, who in the late 1930s and early 1940s began hunting for plant sources of steroid precursors. He discovered that certain plant compounds called sapogenins, particularly diosgenin from wild Mexican yams, could be chemically converted into progesterone through a reaction now known as the Marker degradation. This reaction was the critical first step in making steroid hormones affordable enough for widespread medical use.32The Chemical Record. Russell Earl Marker and the Beginning of the Steroidal Pharmaceutical Industry Before Marker’s work, progesterone had to be extracted from animal sources in tiny quantities at enormous cost. His synthesis from plant material launched the entire steroidal pharmaceutical industry and made possible not only progesterone therapy but the development of oral contraceptives, corticosteroids, and other steroid-based drugs that followed in the subsequent decades.